Literature DB >> 18823821

Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.

Jeroen N Stoop1, Mark A A Claassen, Andrea M Woltman, Rekha S Binda, Ernst J Kuipers, Harry L A Janssen, Renate G van der Molen, Andre Boonstra.   

Abstract

Peripheral blood CD4+CD25+ regulatory T cells (Treg) prevent the development of strong HBV-specific T cell responses in vitro. In this study, we examined the phenotype of FoxP3+ regulatory T cells in the liver of patients with a chronic HBV infection. We showed that the liver contained a population of CD4+FoxP3+ cells that did not express CD25, while these cells were absent from peripheral blood. Interestingly, intrahepatic CD25-FoxP3+CD4+ T cells demonstrated lower expression of HLA-DR and CTLA-4 as compared to their CD25+ counterparts. Patients with a high viral load have a higher proportion of regulatory T cells in the liver, but not in blood, compared to patients with a low viral load. In conclusion, the intrahepatic Treg are phenotypically distinct from peripheral blood Treg. Our data suggest that the higher proportion of intrahepatic Treg observed in patients with a high viral load may explain the lack of control of viral replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823821     DOI: 10.1016/j.clim.2008.07.029

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

1.  Balance lost: T cell immunity in progressive HBV infection.

Authors:  Bertram Bengsch; Robert Thimme
Journal:  Hepatol Int       Date:  2014-01-09       Impact factor: 6.047

Review 2.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.

Authors:  Jiezuan Yang; Guoping Sheng; Dangsheng Xiao; Haiyan Shi; Wei Wu; Haifeng Lu; Hongcui Cao; Lanjuan Li
Journal:  Cell Mol Immunol       Date:  2016-02-22       Impact factor: 11.530

4.  Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

Authors:  Jang-June Park; David K Wong; Abdus S Wahed; William M Lee; Jordan J Feld; Norah Terrault; Mandana Khalili; Richard K Sterling; Kris V Kowdley; Natalie Bzowej; Daryl T Lau; W Ray Kim; Coleman Smith; Robert L Carithers; Keith W Torrey; James W Keith; Danielle L Levine; Daniel Traum; Suzanne Ho; Mary E Valiga; Geoffrey S Johnson; Edward Doo; Anna S F Lok; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2015-12-10       Impact factor: 22.682

5.  Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.

Authors:  Mark A A Claassen; Robert J de Knegt; Harry L A Janssen; André Boonstra
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

Review 6.  T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

7.  Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.

Authors:  Feyza Gunduz; Chaithanya Mallikarjun; Luis A Balart; Srikanta Dash
Journal:  Exp Mol Pathol       Date:  2013-11-08       Impact factor: 3.362

8.  Immune responses elicited by apoB-100-derived peptides in mice.

Authors:  Chrysoulla Pierides; Alexandra Bermudez-Fajardo; Gunilla Nordin Fredrikson; Jan Nilsson; Ernesto Oviedo-Orta
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

9.  Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads.

Authors:  Lara Myers; Ronald J Messer; Aaron B Carmody; Kim J Hasenkrug
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

Review 10.  Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Byung S Kim
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.